VivoSim Labs, Inc. Amortization of Debt Issuance Costs
VivoSim Labs, Inc. (VIVS) reported Amortization of Debt Issuance Costs of $0 for the 12-month period ending 2015-03-31, per its 10-K filed 2015-06-09.
Discontinued › Expense Statement › Operating Expenses
us-gaap:AmortizationOfFinancingCosts · last filed 2015-06-09
- VivoSim Labs, Inc. amortization of debt issuance costs for the quarter ending 2013-03-31 was $0.00, a 100.00% decline year-over-year.
- VivoSim Labs, Inc. amortization of debt issuance costs for the quarter ending 2012-12-31 was $157.00.
- VivoSim Labs, Inc. amortization of debt issuance costs for the quarter ending 2012-09-30 was $0.00.
- VivoSim Labs, Inc. amortization of debt issuance costs for the quarter ending 2012-06-30 was -$157.00.
- VivoSim Labs, Inc. amortization of debt issuance costs for fiscal 2015 was $0.00.
- VivoSim Labs, Inc. amortization of debt issuance costs for fiscal 2014 was $0.00.
- VivoSim Labs, Inc. amortization of debt issuance costs for fiscal 2012 was $319.00K, a 168.07% increase from fiscal 2011.
- VivoSim Labs, Inc. amortization of debt issuance costs for fiscal 2011 was $119.00K.
| Period end | Amortization of Debt Issuance Costs 3 month | Amortization of Debt Issuance Costs 3 month as first filed | Amortization of Debt Issuance Costs 6 month | Amortization of Debt Issuance Costs 9 month | Amortization of Debt Issuance Costs 12 month | Amortization of Debt Issuance Costs 59 month | Amortization of Debt Issuance Costs 62 month | Amortization of Debt Issuance Costs 65 month | Amortization of Debt Issuance Costs 68 month | Amortization of Debt Issuance Costs 71 month | Amortization of Debt Issuance Costs 74 month | Amortization of Debt Issuance Costs 77 month | Amortization of Debt Issuance Costs 80 month | Amortization of Debt Issuance Costs 83 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2015-03-31 | $0.00 10-K · filed 2015-06-09 | |||||||||||||
| 2014-03-31 | $0.00 10-K · filed 2015-06-09 | $438.00K 10-K · filed 2014-06-10 | ||||||||||||
| 2013-12-31 | $438.00K 10-Q · filed 2014-02-06 | |||||||||||||
| 2013-09-30 | $438.00K 10-Q · filed 2013-11-08 | |||||||||||||
| 2013-06-30 | $438.00K 10-Q · filed 2013-08-09 | |||||||||||||
| 2013-03-31 | $0.00 10-K · filed 2015-06-09 | $157.00 derived: sum of 2 quarters · filed 2015-06-09 | $157.00 derived: sum of 3 quarters · filed 2015-06-09 | $0.00 derived: sum of 4 quarters · filed 2015-06-09 | $438.00K 10-KT · filed 2013-05-24 | |||||||||
| 2012-12-31 | $157.00 derived: 10-K 12 month − 10-Q 9 month · filed 2015-06-09 | $157.00 derived: sum of 2 quarters · filed 2015-06-09 | $0.00 derived: sum of 3 quarters · filed 2015-06-09 | $319.00K 10-K · filed 2015-06-09 | $438.00K 10-K · filed 2013-03-15 | |||||||||
| 2012-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-14 | -$157.00 derived: sum of 2 quarters · filed 2012-11-14 | $318.84K 10-Q · filed 2012-11-14 | $438.30K 10-Q · filed 2012-11-14 | ||||||||||
| 2012-06-30 | -$157.00 derived: 10-Q 6 month − 10-K 3 month · filed 2012-08-14 | $318.84K 10-Q · filed 2012-08-14 | $438.30K 10-Q · filed 2012-08-14 | |||||||||||
| 2012-03-31 | $319.00K 10-K · filed 2015-06-09 | $318.84K 10-Q · filed 2012-05-15 | $438.30K 10-Q · filed 2012-05-15 | |||||||||||
| 2011-12-31 | $119.00K 10-K · filed 2014-06-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |